Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP615704.RAarKyuSpIpnfWlOs4JOpKCLKNEZ3Ksw0uTz8DAgknViE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615704.RAarKyuSpIpnfWlOs4JOpKCLKNEZ3Ksw0uTz8DAgknViE130_assertion type Assertion NP615704.RAarKyuSpIpnfWlOs4JOpKCLKNEZ3Ksw0uTz8DAgknViE130_head.
- NP615704.RAarKyuSpIpnfWlOs4JOpKCLKNEZ3Ksw0uTz8DAgknViE130_assertion description "[Taken together, these results suggest that MUT PI3K imparts a more aggressive phenotype in colon cancer cells and could be a potential therapeutic target for treatment of colon cancer patients bearing PIK3CA mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615704.RAarKyuSpIpnfWlOs4JOpKCLKNEZ3Ksw0uTz8DAgknViE130_provenance.
- NP615704.RAarKyuSpIpnfWlOs4JOpKCLKNEZ3Ksw0uTz8DAgknViE130_assertion evidence source_evidence_literature NP615704.RAarKyuSpIpnfWlOs4JOpKCLKNEZ3Ksw0uTz8DAgknViE130_provenance.
- NP615704.RAarKyuSpIpnfWlOs4JOpKCLKNEZ3Ksw0uTz8DAgknViE130_assertion SIO_000772 17575153 NP615704.RAarKyuSpIpnfWlOs4JOpKCLKNEZ3Ksw0uTz8DAgknViE130_provenance.
- NP615704.RAarKyuSpIpnfWlOs4JOpKCLKNEZ3Ksw0uTz8DAgknViE130_assertion wasDerivedFrom befree-2016 NP615704.RAarKyuSpIpnfWlOs4JOpKCLKNEZ3Ksw0uTz8DAgknViE130_provenance.
- NP615704.RAarKyuSpIpnfWlOs4JOpKCLKNEZ3Ksw0uTz8DAgknViE130_assertion wasGeneratedBy ECO_0000203 NP615704.RAarKyuSpIpnfWlOs4JOpKCLKNEZ3Ksw0uTz8DAgknViE130_provenance.